Connor Clark & Lunn Investment Management Ltd. grew its stake in shares of Abbott Laboratories ( NYSE:ABT – Get Rating ) by 273.5% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 544,368 shares of the healthcare product maker's stock after acquiring an additional 398,631 shares during the period. Connor Clark & Lunn Investment Management Ltd.'s holdings in Abbott Laboratories were worth $59,766,000 at the end of the most recent quarter.

https://www.dailypolitical.com/2023/05/23/abbott-laboratories-nyseabt-shares-bought-by-connor-clark-lunn-investment-management-ltd.html

#dailypolitical